Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, Davis
With
National Cancer Institute (NCI)
OBJECTIVES:
Primary
* Evaluate the accuracy of glycan analysis to distinguish between normal healthy control female subjects and those with ovarian epithelial cancer.
Secondary
* Compare the new assay to the standard CA 125 for diagnostic accuracy.
OUTLINE:
* Ovarian cancer patients: Blood samples are obtained periodically for up to 2 years. Patients undergoing surgery have blood samples drawn before and after surgery. Medical charts are reviewed periodically for up to 3 years.
* Healthy volunteers: One blood sample is obtained. Volunteers also complete a 1-page questionnaire.
PROJECTED ACCRUAL: A total of 300 healthy female participants and 400 patients will be accrued for this study.
Age
21–any
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Able to understand consent document for participation in the study
Not pregnant
Negative pregnancy test
Participants must meet 1 of the following criteria:
Patients scheduled for ovarian surgery for an ovarian mass
Healthy female volunteers with no active cancer or history of cancer
Clareo Health | Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
